(2023). A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD. Int J Chron Obstruct Pulmon Dis, 18, 2565-2580. http://doi.org/10.2147/copd.s433326
. M. Bafadhel
First name
M.
Last name
Bafadhel
(2023). QRISK3 underestimates the risk of cardiovascular events in patients with COPD. Thorax. http://doi.org/10.1136/thorax-2023-220615
. (2022). Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population. Erj Open Res, 8. http://doi.org/10.1183/23120541.00606-2021
.